WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Human Rights Council Speakers: Right To Health Underlies All Other Rights, Access To Medicines Key 09/06/2017 Catherine Saez If governments have the obligation to help keep their citizens healthy, many of them are struggling to strengthen their health systems. A variety of hurdles is in the way, and lack of access to medicines is one of them, as underlined by the World Health Organization director general in her address to the United Nations Human Rights Council yesterday. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 Mara Pillinger The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out. Continue reading -> No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 Monika Ermert Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Human Rights Council Speakers: Right To Health Underlies All Other Rights, Access To Medicines Key 09/06/2017 Catherine Saez If governments have the obligation to help keep their citizens healthy, many of them are struggling to strengthen their health systems. A variety of hurdles is in the way, and lack of access to medicines is one of them, as underlined by the World Health Organization director general in her address to the United Nations Human Rights Council yesterday. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 Mara Pillinger The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out. Continue reading -> No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 Monika Ermert Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Human Rights Council Speakers: Right To Health Underlies All Other Rights, Access To Medicines Key 09/06/2017 Catherine Saez If governments have the obligation to help keep their citizens healthy, many of them are struggling to strengthen their health systems. A variety of hurdles is in the way, and lack of access to medicines is one of them, as underlined by the World Health Organization director general in her address to the United Nations Human Rights Council yesterday. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 Mara Pillinger The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out. Continue reading -> No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 Monika Ermert Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 Mara Pillinger The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out. Continue reading -> No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 Monika Ermert Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 Mara Pillinger The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out. Continue reading -> No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 Monika Ermert Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 Mara Pillinger The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out. Continue reading -> No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 Monika Ermert Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 Mara Pillinger The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out. Continue reading -> No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 Monika Ermert Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 Monika Ermert Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy